Guardant Health, Inc. — Form 10-Q
Filed July 30, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 3/100
What the filing says
Standard Sarbanes-Oxley certifications filed July 30, 2026 by Co-CEOs Helmy Eltoukhy and AmirAli Talasaz, and CFO Michael Bell for the quarter ended June 30, 2026. Officers certify financial statements fairly present the company's condition and operations, and that disclosure controls and internal controls over financial reporting are effective. No material weaknesses, deficiencies, or fraud disclosures mentioned.
Why this rating
Boilerplate SOX certification exhibits—routine quarterly filing requirement, no substantive business information disclosed.
See more from July 30, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.